These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]. Hutt V, Klör HU, Wechsler JG, Ditschuneit H. J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054 [Abstract] [Full Text] [Related]
12. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G, Fragiacomo C, Weidmann P, Bachmann C. Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660 [Abstract] [Full Text] [Related]
13. Pathogenesis and management of lipoprotein disorders. Schaefer EJ, Levy RI. N Engl J Med; 1985 May 16; 312(20):1300-10. PubMed ID: 3887163 [No Abstract] [Full Text] [Related]
14. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. V. Evaluation of circulatory hemodynamics based on the measurements of systolic time intervals and the physical analysis of blood circulation]. Olejak B, Szmatłoch E, Brzeźniak R, Gregorczyk J, Pieczul-Mróz J, Jankowska E, Jagła A. Przegl Lek; 1983 May 16; 40(11):797-801. PubMed ID: 6669732 [No Abstract] [Full Text] [Related]
15. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia]. Nowicka G, Kłosiewicz-Latoszek L. Wiad Lek; 1985 Aug 15; 38(16):1179-84. PubMed ID: 4082589 [No Abstract] [Full Text] [Related]
19. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias. Canzler H, Bojanovski D. Artery; 1980 Aug 15; 8(2):171-8. PubMed ID: 7458684 [Abstract] [Full Text] [Related]